Open AccessInteraction of dirhenium(III) tryptophan complex compound with DNA and protein
Author(s) -
A. A. Golichenko,
Н. И. Штеменко,
A.A. Ovcharenko,
A. V. Shtemenko
Publication year - 2021
Publication title -
voprosy himii i himičeskoj tehnologii/voprosy himii i himičeskoj tehnologii
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.278
H-Index - 7
eISSN - 2413-7987
pISSN - 0321-4095
DOI - 10.32434/0321-4095-2021-137-4-35-40
Subject(s) - chemistry , dna , guanine , crystallography , benzothiazole , titration , conjugated system , rhenium , binding constant , binding site , absorption spectroscopy , stereochemistry , photochemistry , nucleotide , inorganic chemistry , biochemistry , organic chemistry , physics , quantum mechanics , gene , polymer
We report about the interactions of dirhenium(III) compound cis-[Re2(Trp)2Cl4(CH3CN)2]Cl2 (I) with bovine serum protein (BSA) and guanine (G4) quadruplexes DNA by UV-Vis titration. Addition of I to BSA led to the interaction between these compounds with binding constant 5.6103 M–1 and hyperchromism (20.9%) of the main protein absorption band (280 nm). These results support our assumption about formation of the additional conjugated systems during the process of interaction with BSA. Stabilization of the quadruple bonded rhenium(III) complex compound was shown in the presence of BSA (the rate of destruction was reduced), that may be explained by interaction between amino acid residues of BSA and quadruple bond of dirhenium(III) complex compound. In addition, we have obtained data about strong hyperchromism (up to 100%) and significant shift of the maximum of absorption (blue shift) towards UV (2–9 nm) and visible (22 nm) regions in the spectra of mixtures G4s and I, that, in our opinion, correlated with a conformational change in DNA and with formation of additional conjugated systems around quadruple bond of I. In a whole, our work confirms the strong binding activity of a cluster dirhenium(III) compound towards G4 quadruplexes, that exceed the binding activity to proteins and witness to preferential interactions of I with G4 DNA in a living cell. These results may be used in DNA "silencing technology" and "antisense therapy".